TAME', MARIAROSA
 Distribuzione geografica
Continente #
NA - Nord America 820
EU - Europa 468
AS - Asia 151
AF - Africa 34
SA - Sud America 1
Totale 1.474
Nazione #
US - Stati Uniti d'America 820
GB - Regno Unito 155
SE - Svezia 75
CN - Cina 54
DE - Germania 54
IT - Italia 54
SG - Singapore 47
IN - India 29
IE - Irlanda 25
UA - Ucraina 24
FR - Francia 22
RU - Federazione Russa 18
EE - Estonia 13
JO - Giordania 13
TG - Togo 11
CH - Svizzera 9
CI - Costa d'Avorio 9
ZA - Sudafrica 9
BG - Bulgaria 7
BE - Belgio 4
NG - Nigeria 4
IR - Iran 3
ES - Italia 2
HR - Croazia 2
MM - Myanmar 2
PL - Polonia 2
BR - Brasile 1
EG - Egitto 1
FI - Finlandia 1
IL - Israele 1
JP - Giappone 1
NL - Olanda 1
UZ - Uzbekistan 1
Totale 1.474
Città #
Southend 143
Fairfield 131
Chandler 80
Ashburn 64
Wilmington 60
Woodbridge 50
Houston 44
Cambridge 43
Ann Arbor 42
Seattle 41
Singapore 41
Princeton 30
Dublin 25
Nanjing 17
Boardman 15
Westminster 14
Amman 13
Padova 13
Lomé 11
Santa Clara 10
Abidjan 9
Bologna 9
San Diego 9
Berlin 8
Bern 8
Dearborn 8
Jacksonville 7
Saint Petersburg 7
Sofia 7
Bremen 5
New York 5
Abeokuta 4
Beijing 4
Brussels 4
Guangzhou 4
Jinan 4
Los Angeles 4
Milan 4
Nanchang 4
Shenyang 4
Turin 4
Cagliari 3
Des Moines 3
Florence 3
Jiaxing 3
Medford 3
Redwood City 3
Rome 3
Aachen 2
Changsha 2
Haikou 2
Norwalk 2
Patheingyi 2
Providence 2
Redmond 2
Tianjin 2
Amsterdam 1
Andover 1
Ardabil 1
Argelato 1
Augusta 1
Buffalo 1
Cairo 1
Channahon 1
Edinburgh 1
Hebei 1
Helsinki 1
Kiev 1
Kilburn 1
Kumar 1
Kunming 1
Lanzhou 1
Leawood 1
London 1
Madrid 1
Medicina 1
Minneapolis 1
Monmouth Junction 1
Muizenberg 1
New Kensington 1
Ningbo 1
Olalla 1
Paris 1
Phoenix 1
Plauen 1
Prescot 1
Sacramento 1
Saint Paul 1
Shanghai 1
São Paulo 1
Tokyo 1
Ulan-ude 1
Walnut 1
Weimar 1
Wuhan 1
Zhengzhou 1
Totale 1.086
Nome #
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 139
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 131
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 125
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 123
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 118
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 117
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 107
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 100
Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. 96
Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation. 95
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report 93
Detection of HCV antigens in liver graft: Relevance to the management of recurrent post-liver transplant hepatitis C. 89
Sirolimus in liver transplant recipients: a large single-center experience. 89
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort 78
Totale 1.500
Categoria #
all - tutte 3.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020356 0 0 4 25 51 46 61 55 53 22 12 27
2020/2021133 37 21 3 2 2 7 3 10 18 8 4 18
2021/2022291 15 6 19 17 23 18 7 16 11 19 100 40
2022/2023324 31 40 23 42 16 24 6 13 65 25 20 19
2023/202483 2 9 1 6 7 12 3 14 16 6 5 2
2024/202583 19 61 3 0 0 0 0 0 0 0 0 0
Totale 1.500